Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

2 treatments under study, led by Cervical Interbody Fusion Surgery Standalone

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 2 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

Trial Status

Completed1
Recruiting1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 1 completed trials

Clinical Trials (2)

Showing 2 of 2 trials
NCT07834749RecruitingPrimary

PMCF Study Fortilink-SC

NCT00942045CompletedPrimary

Osteocel® Plus in Anterior Cervical Discectomy and Fusion (ACDF)

Showing all 2 trials

Research Network

Common Treatments

  • Cervical Interbody Fusion Surgery Standalone1
  • Biologic Osteocel Plus1

Active Sponsors

  • BAAT Medical Products B.V.1
  • NuVasive1
  • Archer Research1
  • Paradigm Spine1

Top Investigators

Related Conditions

  • Stenosis Cervical Spine1

Activity Timeline